NKTR (NKTR) Stock Price & Analysis
NKTR (NKTR) fell 2.85% to USD 74.19 as of September 8, 2026 at 10:17 UTC, according to Nexqual real-time market data.
NKTR last closed at USD 74.19; the session ranged USD 73.66–75.63 on volume of 607,432 shares. Market capitalization is —, with a 52-week range of USD 33.4–109 (NCM). Source: Nexqual, September 8, 2026 at 10:17 UTC.
Key Statistics (as of September 8, 2026 at 10:17 UTC)
| Price | USD 74.19 |
|---|---|
| Change | ▼ 2.85% (down) |
| Previous Close | USD 74.19 |
| Open | USD 74.19 |
| Day Range | USD 73.66 – 75.63 |
| 52-Week Range | USD 33.4 – 109 |
| Volume | 607,432 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (NKTR)
Nexqual's technical model rates NKTR "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 10:17 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 54.44 (neutral) |
| vs SMA50 | Above (USD 71.66) |
| MACD | 0.58 (positive) |
From NKTR's Latest SEC 10-K Filing (filed 2026-03-13)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ALKS | Alkermes plc | USD 46.1 | ▼ 3.39% |
| NBIX | Neurocrine Biosciences, Inc. | USD 155.64 | ▼ 1.36% |
| SGMOQ | Sangamo Therapeutics, Inc. | USD 0.16 | ▼ 5.88% |
| INCY | Incyte Corporation | USD 126.75 | ▼ 1.61% |
| EXEL | Exelixis, Inc. | USD 59.01 | ▲ 0.82% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:17 UTC. This page is informational and not investment advice.